Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$199,706.00
Jan 1, 2022
Individual or sole proprietorship
CIHR-CEPI Leadership Award for Vaccine Research
163346
The specific objectives of this funding opportunity are:
• Promote the career development of mid-career investigators from Canadian academic institutions in vaccine research for infectious diseases;
• Create new knowledge in vaccine research for emerging threats through a mutually beneficial exchange of expertise between Canadian mid-career investigators and CEPI, and support the mobilization of the knowledge created to relevant knowledge users and other stakeholders; and
• Position mid-career Canadian investigators as international leaders in vaccine research for infectious diseases.
$200,000.00
Jan 1, 2022
Individual or sole proprietorship
CIHR-CEPI Leadership Award for Vaccine Research
163345
The specific objectives of this funding opportunity are:
• Promote the career development of mid-career investigators from Canadian academic institutions in vaccine research for infectious diseases;
• Create new knowledge in vaccine research for emerging threats through a mutually beneficial exchange of expertise between Canadian mid-career investigators and CEPI, and support the mobilization of the knowledge created to relevant knowledge users and other stakeholders; and
• Position mid-career Canadian investigators as international leaders in vaccine research for infectious diseases.
$194,880.00
Jan 1, 2022
Individual or sole proprietorship
CIHR-CEPI Leadership Award for Vaccine Research
163347
The specific objectives of this funding opportunity are:
• Promote the career development of mid-career investigators from Canadian academic institutions in vaccine research for infectious diseases;
• Create new knowledge in vaccine research for emerging threats through a mutually beneficial exchange of expertise between Canadian mid-career investigators and CEPI, and support the mobilization of the knowledge created to relevant knowledge users and other stakeholders; and
• Position mid-career Canadian investigators as international leaders in vaccine research for infectious diseases.
$50,000.00
Jan 1, 2022
For-profit organization
Graduate for Research Data Management
986209
At the present time, the United States has a Covid-19 mandate that requires any company over 100 employees to test their employees that have not yet been vaccinated. This mandate requires companies to find logistical services to assist them in rolling out a testing program sometimes amidst thousands of employees in separate states across the country.
$160,000,000.00
Dec 23, 2021
Not-for-profit organization or charity
COVID-19 Response Mechanism Phase 2
7436610 P010788001
Improving access to testing is essential for controlling the spread of COVID-19 through enabling targeted public health measures and use of therapeutics and vaccines as they become available and delivered.
$50,000.00
Dec 22, 2021
220310
220310
Hire specialized expertise for DNA vaccine platform development
$198,367.00
Dec 17, 2021
Not-for-profit organization or charity
Contribution to Fondation Hirondelle - RDC
CFLI-2021-KNSHA-0009
Radio information campaign:
Informing and reducing misinformation about COVID-19 vaccines in the DRC
$30,132.00
Dec 12, 2021
Not-for-profit organization or charity
Contribution to St Gabriels Hospital
CFLI-2021-MPUTO-MW-0004
Response to covid19 pandemic through training of staff on case management, community sensitization on covid19 vaccines and procurement of infection prevention materials including personal protective equipment for staff at St Gabriels Hospital, Malawi
$499,861.00
Dec 1, 2021
Individual or sole proprietorship
COVID Res. Gaps/Priorities - Vaccine Distribution Models
163273
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$493,717.00
Dec 1, 2021
Individual or sole proprietorship
COVID Res. Gaps/Priorities - Vaccine Distribution Models
163275
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).